)
Micropos Medical (MPOS) investor relations material
Micropos Medical Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Net sales for Jan–Jun 2026 were 1,593 Tkr, down from 5,979 Tkr year-over-year.
Result after financial items was -16,458 Tkr compared to -9,803 Tkr year-over-year.
The quarter saw high activity, new installations, and continued international expansion, especially in Spain and the US.
NHS England adopted SBRT as standard for localized prostate cancer, increasing relevance for Raypilot System.
A new share issue raised 24.5 Mkr after costs, supporting market expansion.
Financial highlights
Net sales for Q2 2026 were 1,108 Tkr, down from 3,349 Tkr in Q2 2025.
Result after financial items for Q2 was -9,514 Tkr (Q2 2025: -4,277 Tkr).
Cash flow for the period was 7,517 Tkr (13,104 Tkr year-over-year).
Equity at period end was 21,805 Tkr (25,591 Tkr year-over-year).
Solid equity ratio at 80% (83% year-over-year).
Outlook and guidance
Market trends favor shorter, more precise radiotherapy, supporting future growth.
NHS England’s adoption of SBRT is expected to drive demand.
Ongoing studies and clinical results support broader adoption of Raypilot System.
- Sales and equity fell, but MDR certification and new deals highlight growing clinical traction.MPOS
Q1 202630 Apr 2026 - Net sales surged 113% year-over-year, but continued losses highlight the need for new capital.MPOS
Q4 202530 Jan 2026 - Net sales surged and losses narrowed, but new capital will be needed in early 2026.MPOS
Q3 202531 Oct 2025 - Net sales doubled and cash strengthened, with Raypilot System adoption accelerating in Europe.MPOS
Q2 202531 Jul 2025 - First US order and strong clinical evidence position Micropos for growth as SBRT adoption rises.MPOS
Q3 202413 Jun 2025 - Sales up, losses down, and Raypilot System gains traction in key European markets.MPOS
Q2 202413 Jun 2025 - Strong sales growth and full rights issue support expansion and clinical adoption.MPOS
Q1 20256 Jun 2025 - Strong sales growth and SBRT momentum drive Raypilot System adoption, but liquidity risks persist.MPOS
Q4 20245 Jun 2025
Next Micropos Medical earnings date
Next Micropos Medical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)